Title:
HETEROARYL COMPOUND HAVING PHARMACEUTICAL ACTIVITY
Document Type and Number:
WIPO Patent Application WO/2018/233655
Kind Code:
A1
Abstract:
The present invention provides a novel compound having selective inhibitory activity against Btk and better metabolic stability.
Inventors:
LIU XIN (CN)
YUAN ZHEDONG (CN)
KONG RUI (CN)
CHEN SHAN (CN)
YUAN ZHEDONG (CN)
KONG RUI (CN)
CHEN SHAN (CN)
Application Number:
PCT/CN2018/092122
Publication Date:
December 27, 2018
Filing Date:
June 21, 2018
Export Citation:
Assignee:
SHANGHAI DUDE MEDICAL TECH CO LTD (CN)
International Classes:
C07D487/04; A61P29/00; A61P35/00; C07D473/34
Domestic Patent References:
| WO2014130856A2 | 2014-08-28 | |||
| WO2016010926A1 | 2016-01-21 | |||
| WO2008121742A2 | 2008-10-09 | |||
| WO2010009342A2 | 2010-01-21 |
Foreign References:
| CN107501270A | 2017-12-22 | |||
| CN106279172A | 2017-01-04 | |||
| CN101674834A | 2010-03-17 | |||
| CN103917545A | 2014-07-09 | |||
| JP2010504324A | 2010-02-12 | |||
| CN201180026837A | 2011-05-30 | |||
| CN201280045383A | 2012-07-11 |
Other References:
NATURE, vol. 361, 1993, pages 226 - 233
ANTICANCER AGENTS IN MEDICINAL CHEMISTRY, vol. 7, no. 6, 2007, pages 624 - 632
LCK-DELETION MICE, vol. 16, 1998, pages 2351 - 2356
See also references of EP 3643716A4
ANTICANCER AGENTS IN MEDICINAL CHEMISTRY, vol. 7, no. 6, 2007, pages 624 - 632
LCK-DELETION MICE, vol. 16, 1998, pages 2351 - 2356
See also references of EP 3643716A4
Attorney, Agent or Firm:
TUO YING LAW OFFICES (SHANGHAI) (CN)
Download PDF: